Patent classifications
C12Q2565/131
Controlled cell-cell interaction assay
Disclosed herein include methods, devices, kits, and systems for nucleic acid sequencing, for example, to determine cell-cell interaction using a dielectrophoresis microfluidic device.
Controlled cell-cell interaction assay
Disclosed herein include methods, devices, kits, and systems for nucleic acid sequencing, for example, to determine cell-cell interaction using a dielectrophoresis microfluidic device.
PROGRAMMABLE NUCLEASE RESISTANCE OF NUCLEIC ACID ASSEMBLIES
The present invention provides nuclease-resistant nucleic acid nanostructures, pharmaceutical compositions thereof, pharmaceutical and diagnostic uses thereof as well as a method of producing nucleic acid nanostructures.
PROGRAMMABLE NUCLEASE RESISTANCE OF NUCLEIC ACID ASSEMBLIES
The present invention provides nuclease-resistant nucleic acid nanostructures, pharmaceutical compositions thereof, pharmaceutical and diagnostic uses thereof as well as a method of producing nucleic acid nanostructures.